Mml Investors Services, LLC Seagen Inc. Transaction History

Mml Investors Services, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $577,402 - $651,722	-3,015 Reduced 30.82%	6,769 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $43,344 - $47,643	231 Added 2.42%	9,784 $1.88 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $105,134 - $167,337	-824 Reduced 7.94%	9,553 $1.93 Million
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $183,801 - $217,940	-1,566 Reduced 13.11%	10,377 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $405,945 - $540,510	3,001 Added 33.56%	11,943 $1.63 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $124,913 - $205,870	1,148 Added 14.73%	8,942 $1.58 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $24,878 - $32,832	-208 Reduced 2.6%	7,794 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $38,921 - $52,104	273 Added 3.53%	8,002 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $8,119 - $9,679	57 Added 0.74%	7,729 $1.31 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $37,822 - $45,108	280 Added 3.79%	7,672 $1.21 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $253,568 - $351,835	1,844 Added 33.24%	7,392 $1.03 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $913,367 - $1.18 Million	5,548 New	5,548 $972,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.